UnitedHealth Group Incorporated (UNH) Director Kenneth Irwin Shine Sells 457 Shares of Stock

UnitedHealth Group Incorporated (NYSE:UNH) Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction dated Tuesday, November 14th. The stock was sold at an average price of $211.03, for a total transaction of $96,440.71. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

UnitedHealth Group Incorporated (NYSE:UNH) traded down $1.23 during trading on Friday, reaching $209.90. 1,881,773 shares of the company’s stock were exchanged, compared to its average volume of 3,109,878. The firm has a market cap of $204,130.00, a price-to-earnings ratio of 22.05, a PEG ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a 12 month low of $148.56 and a 12 month high of $213.93. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. During the same period in the prior year, the business earned $2.17 EPS. analysts predict that UnitedHealth Group Incorporated will post 9.99 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.43%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 34.09%.

ILLEGAL ACTIVITY NOTICE: “UnitedHealth Group Incorporated (UNH) Director Kenneth Irwin Shine Sells 457 Shares of Stock” was originally posted by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this piece on another domain, it was copied illegally and republished in violation of United States and international copyright and trademark laws. The legal version of this piece can be accessed at https://sportsperspectives.com/2017/11/18/unitedhealth-group-incorporated-unh-director-kenneth-irwin-shine-sells-457-shares-of-stock.html.

A number of institutional investors have recently added to or reduced their stakes in the business. Capital International Investors raised its holdings in shares of UnitedHealth Group by 399.3% in the 3rd quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares in the last quarter. Jennison Associates LLC raised its holdings in shares of UnitedHealth Group by 146.0% in the 3rd quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares in the last quarter. Harbour Capital Advisors LLC raised its holdings in shares of UnitedHealth Group by 18,383.4% in the 2nd quarter. Harbour Capital Advisors LLC now owns 2,516,706 shares of the healthcare conglomerate’s stock valued at $13,573,000 after purchasing an additional 2,503,090 shares in the last quarter. Janus Henderson Group PLC raised its holdings in shares of UnitedHealth Group by 1,820.1% in the 2nd quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in shares of UnitedHealth Group by 2.5% in the 2nd quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. Institutional investors own 86.00% of the company’s stock.

A number of research analysts have weighed in on UNH shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $208.00 price objective on shares of UnitedHealth Group in a research report on Friday, July 21st. ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Zacks Investment Research cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $205.00 target price (up previously from $203.00) on shares of UnitedHealth Group in a research note on Friday, July 21st. Finally, Sanford C. Bernstein reissued an “outperform” rating and set a $210.00 target price (up previously from $190.00) on shares of UnitedHealth Group in a research note on Saturday, July 22nd. Three analysts have rated the stock with a hold rating and twenty-four have assigned a buy rating to the stock. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $216.65.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply